Atopic Dermatitis Clinical Trials in Morgantown, West Virginia

4 studies are recruiting for atopic dermatitis in Morgantown, West Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

    This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic dia…

    Stage
    Not phased
    Ages
    12 to 89
    Site
    West Virginia Research Institute, Morgantown, West Virginia
    Locations
    10 in total
    Run by
    Castle Biosciences Incorporated

    See if you can join NCT07645820 on ClinicalTrials.gov

  2. A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study compares upadacitinib to dupil…

    Stage
    Phase 3
    Ages
    2 to 11
    Site
    West Virginia University Hospitals /ID# 265114, Morgantown, West Virginia
    Locations
    150 in total
    Run by
    AbbVie

    See if you can join NCT06461897 on ClinicalTrials.gov

  3. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy an…

    Stage
    Phase 3
    Ages
    18 to 63
    Site
    West Virginia Research Institute - Morgantown /ID# 264930, Morgantown, West Virginia
    Locations
    128 in total
    Run by
    AbbVie

    See if you can join NCT06389136 on ClinicalTrials.gov

  4. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 8725, Morgantown, West Virginia
    Locations
    108 in total
    Run by
    Galderma R&D

    See if you can join NCT06988605 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.